HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4,4'- (1,2- dimethyl- 1,2- ethanediyl)bis- 2,6- piperazinedione

structure given in first source; RN given refers to cpd without isomeric designation
Also Known As:
ICRF 193; ICRF-193
Networked: 29 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Downes, C Stephen: 3 articles (12/2003 - 05/2002)
2. Kaufmann, William K: 3 articles (12/2003 - 05/2002)
3. Errington, Rachel J: 2 articles (04/2010 - 08/2007)
4. Smith, Paul J: 2 articles (04/2010 - 08/2007)
5. Simpson, Dennis A: 2 articles (12/2003 - 05/2002)
6. Cortés, F: 2 articles (09/2003 - 10/2001)
7. Pastor, N: 2 articles (09/2003 - 10/2001)
8. Mateos, S: 2 articles (09/2003 - 10/2001)
9. Domínguez, I: 2 articles (09/2003 - 10/2001)
10. Deming, Paula B: 2 articles (09/2002 - 05/2002)

Related Diseases

1. Poisoning
2. Muscle Cramp (Cramp)
3. Lung Neoplasms (Lung Cancer)
4. Hypersensitivity (Allergy)
5. Polyploidy

Related Drugs and Biologics

1. Type II DNA Topoisomerases (Topoisomerase II)
2. Detergents (Detergent)
3. Etoposide (VP 16)
4. DNA (Deoxyribonucleic Acid)
5. Topoisomerase II Inhibitors
6. Razoxane (Dexrazoxane)
7. Phosphotransferases (Kinase)
8. 1,2-bis(3,5-dioxopiperazin-1-yl)ethane
9. Topoisomerase Inhibitors
10. Catalytic DNA (Deoxyribozyme)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Aftercare (After-Treatment)